Statistics for Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
Total visits
| views | |
|---|---|
| Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension | 55 |
Total visits per month
| views | |
|---|---|
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
File Visits
| views | |
|---|---|
| rmdopen-2021-001714.pdf | 45 |
Top country views
| views | |
|---|---|
| United States | 48 |
| France | 2 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Ann Arbor | 2 |
| Paris | 2 |
| Cambridge | 1 |
| Fairfield | 1 |
| Grayslake | 1 |
| Indianapolis | 1 |